Skip to main content
Premium Trial:

Request an Annual Quote

Augustine Yee

Premium

Archemix said this week that it has appointed Augustine Yee as vice president of business development.

Prior to joining Archemix, Yee was vice president and head of business and corporate development at Prometheus Laboratories. He has also held positions at Deltagen and the law firm of Pillsbury, Madison & Sutro.

Yee holds a BS in molecular biology from the University of California, San Diego, as well as a JD from Pepperdine University School of Law, according to Archemix.

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.